Treatment of the cardiovascular manifestations of phosphine poisoning with trimetazidine, a new antiischemic drug.
Dueñas
A
A
Pérez-Castrillon
J L
JL
Cobos
M A
MA
Herreros
V
V
D000280:Administration, Inhalation; D000328:Adult; D017607:Aluminum Compounds / Q000008:administration & dosage / Q000506:poisoning*; D004562:Electrocardiography / Q000187:drug effects; D004630:Emergencies; D006801:Humans; D008297:Male; D009784:Occupational Diseases / Q000139:chemically induced* / Q000188:drug therapy; D010720:Phosphines / Q000008:administration & dosage / Q000506:poisoning*; D011041:Poisoning / Q000188:drug therapy*; D017180:Tachycardia, Ventricular / Q000139:chemically induced* / Q000188:drug therapy; D014292:Trimetazidine / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D017607:Aluminum Compounds; D010720:Phosphines; D014665:Vasodilator Agents; C001864:aluminum phosphide; D014292:Trimetazidine